A phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6

Toll Pathway-Dependent Blockade of CD4 ⁺ CD25 ⁺ T Cell-Mediated Suppression by Dendritic Cells

Chandrashekhar Pasare, Ruslan Medzhitov · Science · 2003 · 2K citations

Life Sciences, Immunology, Adaptive Immunity +16

Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway

Lin‐Hung Wei, Min‐Liang Kuo, Chi‐An Chen et al. · Oncogene · 2003 · 534 citations

Medicine, Cancer Biology, Oncology +12

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6

Marina Ratta, Francesco Fagnoni, Antonio Curti et al. · Blood · 2002 · 447 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells

Leonid S. Metelitsa, Kenneth I. Weinberg, Peter D. Emanuel et al. · Leukemia · 2003 · 160 citations

Life Sciences, Immunology, Oncology +13

Gene Immunotherapy in Murine Acute Myeloid Leukemia: Granulocyte-Macrophage Colony-Stimulating Factor Tumor Cell Vaccines Elicit More Potent Antitumor Immunity Compared With B7 Family and Other Cytokine Vaccines

Kyriaki Dunussi‐Joannopoulos, Glenn Dranoff, Howard J. Weinstein et al. · Blood · 1998 · 118 citations · Full text

Medicine, Immunology, Oncology +17